BackErytech Pharma Overview

Erytech Pharma Total Liabilities

Latest total liabilities for ERYP: $0.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$0.00

Peer average

Loading

Erytech Pharma Total Liabilities History

Loading

Erytech Pharma vs. peers: Total Liabilities Comparison

Loading

Erytech Pharma Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Erytech Pharma (ERYP) FAQ

The latest total liabilities for ERYP is $0 as of March 2023. Investors often review this figure alongside Erytech Pharma's historical trend and sector peers before judging valuation or financial health.

A total liabilities figure of $0 for ERYP is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ERYP's total liabilities ($0), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Erytech Pharma's total liabilities against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.